Biomarkers help in the diagnosis and monitoring of disease, but robust biomarkers can be difficult to discover and validate. This Review explores the state of biomarker discovery for axial spondyloarthritis and suggests future developments to advance this field.
- Matthew A. Brown
- Zhixiu Li
- Kim-Anh Lê Cao